Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Mesa Laboratories (MLAB) over the last 11 years, with Q4 2025 value amounting to $316000.0.

  • Mesa Laboratories' Exchange Rate Effect rose 17707.32% to $316000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.6 million, marking a year-over-year increase of 1234285.71%. This contributed to the annual value of $1.3 million for FY2025, which is 46406.69% up from last year.
  • As of Q4 2025, Mesa Laboratories' Exchange Rate Effect stood at $316000.0, which was up 17707.32% from -$104000.0 recorded in Q3 2025.
  • Over the past 5 years, Mesa Laboratories' Exchange Rate Effect peaked at $2.6 million during Q2 2021, and registered a low of -$2.1 million during Q3 2021.
  • Its 5-year average for Exchange Rate Effect is -$66500.0, with a median of -$316500.0 in 2023.
  • As far as peak fluctuations go, Mesa Laboratories' Exchange Rate Effect crashed by 33128.49% in 2021, and later skyrocketed by 95771.43% in 2025.
  • Over the past 5 years, Mesa Laboratories' Exchange Rate Effect (Quarter) stood at -$834000.0 in 2021, then soared by 279.02% to $1.5 million in 2022, then decreased by 29.54% to $1.1 million in 2023, then crashed by 138.97% to -$410000.0 in 2024, then surged by 177.07% to $316000.0 in 2025.
  • Its Exchange Rate Effect was $316000.0 in Q4 2025, compared to -$104000.0 in Q3 2025 and $1.5 million in Q2 2025.